# cofactor_0168

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `cofactor`  
**Author expected answer:** **A** — FMN

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MALLTDDFDAVVASRRAVRAFLPTPISRKLISEIIDIARLAPSNSNTQPWSIHVLTGEPKQALSALLGIAHNDPSADPLAHLPDDLARKYRERQEKWGELFYGLHQIDKCDDAGRARVSGLNFDFFGAPVGLIFTIDSNLKKYSWLDYGLFLQTLMLTARSRGLSTCPQVSFARFQSLIKDFLHLDDSQEIVCGMSLGYADENATVNSLRMPREMAQGFTHFMGFDR

[Multiple Choices]
A. FMN
B. NAD(+)
C. Fe(2+)
D. tungstopterin
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Predicting Protein Cofactor, which is to identify the specific cofactor required for a given protein's catalytic activity. A cofactor is a non-protein chemical compound or metallic ion that is essential for an enzyme's function. Based on the provided protein sequence, you will need to determine which of the multiple-choice options is the correct cofactor.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt entry annotates FMN as the cofactor and states that one FMN binds per subunit. However, this annotation is transferred by similarity, not direct experimental evidence for this exact protein.

Citations as saved: [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence and choices alone do not establish which cofactor this particular enzyme binds; a reductase function, even if inferred, would not by itself distinguish FMN from the other options.


**Missing item-specific fact**

> The protein-specific FMN-binding annotation, or equivalent experimental evidence, is absent from the question input.


**Reason**

> Choosing FMN depends on an item-specific cofactor fact not supplied in the prompt, rather than a sufficiently discriminating general biological argument.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied reviewer evidence identifies FMN as the annotated cofactor; no competing option is supported by the evidence.


### Important caveats

- The cofactor annotation is based on similarity to another UniProtKB entry (ECO:0000250), so it should not be represented as a direct experimental measurement for this sequence.
- The evidence states that FMN binds per subunit; it does not independently establish that FMN is essential for catalytic activity in this exact protein.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence and choices alone do not establish which cofactor this particular enzyme binds; a reductase function, even if inferred, would not by itself distinguish FMN from the other options.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific FMN-binding annotation, or equivalent experimental evidence, is absent from the question input.",
    "reason": "Choosing FMN depends on an item-specific cofactor fact not supplied in the prompt, rather than a sufficiently discriminating general biological argument."
  },
  "case_id": "cofactor_0168",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry annotates FMN as the cofactor and states that one FMN binds per subunit. However, this annotation is transferred by similarity, not direct experimental evidence for this exact protein."
  },
  "important_caveats": [
    "The cofactor annotation is based on similarity to another UniProtKB entry (ECO:0000250), so it should not be represented as a direct experimental measurement for this sequence.",
    "The evidence states that FMN binds per subunit; it does not independently establish that FMN is essential for catalytic activity in this exact protein."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied reviewer evidence identifies FMN as the annotated cofactor; no competing option is supported by the evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "cofactor_0168",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry annotates FMN as the cofactor and states that one FMN binds per subunit. However, this annotation is transferred by similarity, not direct experimental evidence for this exact protein.",
    "evidence_ids": ["C5", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence and choices alone do not establish which cofactor this particular enzyme binds; a reductase function, even if inferred, would not by itself distinguish FMN from the other options.",
    "missing_item_specific_fact": "The protein-specific FMN-binding annotation, or equivalent experimental evidence, is absent from the question input.",
    "reason": "Choosing FMN depends on an item-specific cofactor fact not supplied in the prompt, rather than a sufficiently discriminating general biological argument."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied reviewer evidence identifies FMN as the annotated cofactor; no competing option is supported by the evidence."
  },
  "important_caveats": [
    "The cofactor annotation is based on similarity to another UniProtKB entry (ECO:0000250), so it should not be represented as a direct experimental measurement for this sequence.",
    "The evidence states that FMN binds per subunit; it does not independently establish that FMN is essential for catalytic activity in this exact protein."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt Q9FD36 (PNBA_PSEPU, 4-nitrobenzoate reductase, EC 1.7.1.-) annotates FMN (CHEBI:58210) as the cofactor, binding 1 FMN per subunit. The sequence in the question matches this entry exactly (227 aa, SHA-256 confirmed). However, the evidence code is ECO:0000250 (similarity transfer from A0R6D0), not direct experimental determination for this specific protein. The EC 1.7.1.- classification (nitrobenzoate reductase) is consistent with a flavoprotein oxidoreductase requiring FMN.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H1](#evidence-h1), [H2](#evidence-h2), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains recognizable flavoprotein signatures: a Rossmann-fold nucleotide-binding region in the N-terminus (e.g., 'GAPVGLIFTID' containing a GxGxxG-like pattern) and the 'GLNFD' motif, which is a hallmark of FMN-binding nitroreductase-family oxidoreductases. These motifs are inconsistent with tungstopterin-dependent enzymes (typically large, multi-subunit tungsten enzymes with very different architectures) and with simple Fe(2+)-binding sites (which use His/Asp/Glu clusters). While NAD+ also uses Rossmann folds, the specific 'GLNFD' and 'GLIFTID' motifs are more diagnostic of FMN-dependent oxidoreductases than NAD+-dependent dehydrogenases. The small protein size (227 aa) is also consistent with a monomeric flavoprotein rather than a large tungsten enzyme.


**Missing item-specific fact**

> None critical. The flavoprotein motifs are identifiable from the sequence. The exact cofactor assignment relies on the nitroreductase-family motif recognition, which is part of general enzymology knowledge.


**Reason**

> A knowledgeable biologist can identify the Rossmann fold and the 'GLNFD' motif as characteristic of FMN-dependent oxidoreductases, distinguishing FMN from the other three options (tungstopterin, Fe(2+), NAD+) through sequence-motif reasoning. The argument is not trivial but is within the scope of general flavoprotein biochemistry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Tungstopterin and Fe(2+) are clearly inconsistent with the observed flavoprotein architecture. NAD+ is the closest distractor due to shared Rossmann-fold usage, but the 'GLNFD' motif and nitroreductase-family context favor FMN. No other option is genuinely defensible.


### Important caveats

- The FMN cofactor annotation carries evidence code ECO:0000250 (similarity transfer from A0R6D0), not direct experimental proof for this specific protein.
- The protein was first publicly released in UniProt on 2025-02-05; the author's source snapshot date is unknown. The sequence has been stable since 2001-03-01.
- The reviewer-only UniProt accession (Q9FD36) was inferred mechanically and was not available to the evaluated model.
- Distinguishing FMN from NAD+ by sequence alone requires specialized knowledge of flavoprotein binding motifs; a generalist might find this step non-trivial, but it remains within the scope of enzymology reasoning rather than pure lookup.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains recognizable flavoprotein signatures: a Rossmann-fold nucleotide-binding region in the N-terminus (e.g., 'GAPVGLIFTID' containing a GxGxxG-like pattern) and the 'GLNFD' motif, which is a hallmark of FMN-binding nitroreductase-family oxidoreductases. These motifs are inconsistent with tungstopterin-dependent enzymes (typically large, multi-subunit tungsten enzymes with very different architectures) and with simple Fe(2+)-binding sites (which use His/Asp/Glu clusters). While NAD+ also uses Rossmann folds, the specific 'GLNFD' and 'GLIFTID' motifs are more diagnostic of FMN-dependent oxidoreductases than NAD+-dependent dehydrogenases. The small protein size (227 aa) is also consistent with a monomeric flavoprotein rather than a large tungsten enzyme.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None critical. The flavoprotein motifs are identifiable from the sequence. The exact cofactor assignment relies on the nitroreductase-family motif recognition, which is part of general enzymology knowledge.",
    "reason": "A knowledgeable biologist can identify the Rossmann fold and the 'GLNFD' motif as characteristic of FMN-dependent oxidoreductases, distinguishing FMN from the other three options (tungstopterin, Fe(2+), NAD+) through sequence-motif reasoning. The argument is not trivial but is within the scope of general flavoprotein biochemistry."
  },
  "case_id": "cofactor_0168",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H1",
      "H2",
      "H4"
    ],
    "judgment": "supported",
    "reason": "UniProt Q9FD36 (PNBA_PSEPU, 4-nitrobenzoate reductase, EC 1.7.1.-) annotates FMN (CHEBI:58210) as the cofactor, binding 1 FMN per subunit. The sequence in the question matches this entry exactly (227 aa, SHA-256 confirmed). However, the evidence code is ECO:0000250 (similarity transfer from A0R6D0), not direct experimental determination for this specific protein. The EC 1.7.1.- classification (nitrobenzoate reductase) is consistent with a flavoprotein oxidoreductase requiring FMN."
  },
  "important_caveats": [
    "The FMN cofactor annotation carries evidence code ECO:0000250 (similarity transfer from A0R6D0), not direct experimental proof for this specific protein.",
    "The protein was first publicly released in UniProt on 2025-02-05; the author's source snapshot date is unknown. The sequence has been stable since 2001-03-01.",
    "The reviewer-only UniProt accession (Q9FD36) was inferred mechanically and was not available to the evaluated model.",
    "Distinguishing FMN from NAD+ by sequence alone requires specialized knowledge of flavoprotein binding motifs; a generalist might find this step non-trivial, but it remains within the scope of enzymology reasoning rather than pure lookup."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Tungstopterin and Fe(2+) are clearly inconsistent with the observed flavoprotein architecture. NAD+ is the closest distractor due to shared Rossmann-fold usage, but the 'GLNFD' motif and nitroreductase-family context favor FMN. No other option is genuinely defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "cofactor_0168",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt Q9FD36 (PNBA_PSEPU, 4-nitrobenzoate reductase, EC 1.7.1.-) annotates FMN (CHEBI:58210) as the cofactor, binding 1 FMN per subunit. The sequence in the question matches this entry exactly (227 aa, SHA-256 confirmed). However, the evidence code is ECO:0000250 (similarity transfer from A0R6D0), not direct experimental determination for this specific protein. The EC 1.7.1.- classification (nitrobenzoate reductase) is consistent with a flavoprotein oxidoreductase requiring FMN.",
    "evidence_ids": ["C1", "C4", "C5", "H1", "H2", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains recognizable flavoprotein signatures: a Rossmann-fold nucleotide-binding region in the N-terminus (e.g., 'GAPVGLIFTID' containing a GxGxxG-like pattern) and the 'GLNFD' motif, which is a hallmark of FMN-binding nitroreductase-family oxidoreductases. These motifs are inconsistent with tungstopterin-dependent enzymes (typically large, multi-subunit tungsten enzymes with very different architectures) and with simple Fe(2+)-binding sites (which use His/Asp/Glu clusters). While NAD+ also uses Rossmann folds, the specific 'GLNFD' and 'GLIFTID' motifs are more diagnostic of FMN-dependent oxidoreductases than NAD+-dependent dehydrogenases. The small protein size (227 aa) is also consistent with a monomeric flavoprotein rather than a large tungsten enzyme.",
    "missing_item_specific_fact": "None critical. The flavoprotein motifs are identifiable from the sequence. The exact cofactor assignment relies on the nitroreductase-family motif recognition, which is part of general enzymology knowledge.",
    "reason": "A knowledgeable biologist can identify the Rossmann fold and the 'GLNFD' motif as characteristic of FMN-dependent oxidoreductases, distinguishing FMN from the other three options (tungstopterin, Fe(2+), NAD+) through sequence-motif reasoning. The argument is not trivial but is within the scope of general flavoprotein biochemistry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Tungstopterin and Fe(2+) are clearly inconsistent with the observed flavoprotein architecture. NAD+ is the closest distractor due to shared Rossmann-fold usage, but the 'GLNFD' motif and nitroreductase-family context favor FMN. No other option is genuinely defensible."
  },
  "important_caveats": [
    "The FMN cofactor annotation carries evidence code ECO:0000250 (similarity transfer from A0R6D0), not direct experimental proof for this specific protein.",
    "The protein was first publicly released in UniProt on 2025-02-05; the author's source snapshot date is unknown. The sequence has been stable since 2001-03-01.",
    "The reviewer-only UniProt accession (Q9FD36) was inferred mechanically and was not available to the evaluated model.",
    "Distinguishing FMN from NAD+ by sequence alone requires specialized knowledge of flavoprotein binding motifs; a generalist might find this step non-trivial, but it remains within the scope of enzymology reasoning rather than pure lookup."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `Q9FD36` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 59. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9FD36.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:47.892738+00:00.  

```json
"Q9FD36"
```

Source SHA-256: `79da8ba5f66886d6f25666f32850cc113bc28c677b3bb972cafdd4832f092ca5`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9FD36.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:47.892738+00:00.  

```json
{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"11157934","source":"PubMed"}],"value":"1.7.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"11157934","source":"PubMed"}],"value":"4-nitrobenzoate reductase"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"11157934","source":"PubMed"}],"value":"4NBen reductase"}]}}
```

Source SHA-256: `79da8ba5f66886d6f25666f32850cc113bc28c677b3bb972cafdd4832f092ca5`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9FD36.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:47.892738+00:00.  

```json
{"cofactors":[{"cofactorCrossReference":{"database":"ChEBI","id":"CHEBI:58210"},"evidences":[{"evidenceCode":"ECO:0000250","id":"A0R6D0","source":"UniProtKB"}],"name":"FMN"}],"commentType":"COFACTOR","note":{"texts":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"A0R6D0","source":"UniProtKB"}],"value":"Binds 1 FMN per subunit."}]}}
```

Source SHA-256: `79da8ba5f66886d6f25666f32850cc113bc28c677b3bb972cafdd4832f092ca5`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9FD36?format=txt&versions=59)  
**Locator:** `lines 1-13`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 59 / 1.  
**Retrieved:** 2026-11-02T04:32:49.936444+00:00.  

```text
ID   PNBA_PSEPU              Reviewed;         227 AA.
AC   Q9FD36;
DT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-JAN-2026, entry version 59.
DE   RecName: Full=4-nitrobenzoate reductase {ECO:0000303|PubMed:11157934};
DE            Short=4NBen reductase {ECO:0000303|PubMed:11157934};
DE            EC=1.7.1.- {ECO:0000269|PubMed:11157934};
GN   Name=pnbA {ECO:0000303|PubMed:11157934};
OS   Pseudomonas putida (Arthrobacter siderocapsulatus).
OC   Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria;
OC   Pseudomonadales; Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=303;
```

Source SHA-256: `b8e05036a664f774b75486960f2bb65b17e0fc9481338a912a9e57c2a38f1637`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9FD36?format=txt&versions=59)  
**Locator:** `lines 6-8`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 59 / 1.  
**Retrieved:** 2026-11-02T04:32:49.936444+00:00.  

```text
DE   RecName: Full=4-nitrobenzoate reductase {ECO:0000303|PubMed:11157934};
DE            Short=4NBen reductase {ECO:0000303|PubMed:11157934};
DE            EC=1.7.1.- {ECO:0000269|PubMed:11157934};
```

Source SHA-256: `b8e05036a664f774b75486960f2bb65b17e0fc9481338a912a9e57c2a38f1637`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9FD36?format=txt&versions=59)  
**Locator:** `lines 35-38`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 59 / 1.  
**Retrieved:** 2026-11-02T04:32:49.936444+00:00.  

```text
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000250|UniProtKB:A0R6D0};
CC       Note=Binds 1 FMN per subunit. {ECO:0000250|UniProtKB:A0R6D0};
```

Source SHA-256: `b8e05036a664f774b75486960f2bb65b17e0fc9481338a912a9e57c2a38f1637`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/cofactor.json), zero-based source row 168. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
